What is Teclistamab: Uses, Dosage, Side Effects and More

Teclistamab is a targeted cancer medication that helps your immune system fight multiple myeloma, a type of blood cancer. This injection works by connecting cancer cells to your body's natural immune cells, helping them work together to destroy the cancer.

You might be reading this because your doctor has mentioned teclistamab as a treatment option, or perhaps you're researching on behalf of a loved one. Understanding how this medication works can help you feel more prepared for conversations with your healthcare team.

What is Teclistamab?

Teclistamab is a prescription medication that belongs to a class of drugs called bispecific T-cell engager antibodies. Think of it as a molecular bridge that helps your immune system recognize and attack cancer cells more effectively.

The medication comes as a subcutaneous injection, which means it's given under the skin rather than through an IV. This makes treatment more convenient since you can receive it at your doctor's office relatively quickly.

Teclistamab specifically targets two proteins at once - one found on multiple myeloma cancer cells and another on your T-cells, which are important immune system fighters. By linking these together, the medication helps your body's natural defenses work more efficiently against the cancer.

What is Teclistamab Used For?

Teclistamab is primarily used to treat multiple myeloma in adults whose cancer has returned or hasn't responded to other treatments. Your doctor might recommend this medication if you've already tried at least four different types of multiple myeloma treatments.

Multiple myeloma affects plasma cells, which are a type of white blood cell that normally helps fight infections. When these cells become cancerous, they multiply uncontrollably and can crowd out healthy blood cells in your bone marrow.

This medication is typically considered when other standard treatments haven't worked well enough. Your oncologist will carefully evaluate your specific situation, including your overall health and previous treatments, before recommending teclistamab.

How Does Teclistamab Work?

Teclistamab works by acting as a connector between your immune system and cancer cells. The medication binds to a protein called BCMA that's found on multiple myeloma cells, while also attaching to CD3 proteins on your T-cells.

Once these connections are made, your T-cells become activated and can better recognize the cancer cells as targets that need to be eliminated. This process helps your immune system mount a stronger attack against the multiple myeloma.

This is considered a moderately strong cancer treatment that can be quite effective, but it also requires careful monitoring. The medication essentially recruits your body's own immune system to fight the cancer, which can lead to powerful results but also means your immune system becomes very active.

How Should I Take Teclistamab?

Teclistamab is given as an injection under the skin by your healthcare provider. You'll receive the medication at your doctor's office or infusion center, not at home.

Before starting treatment, you'll need to take medications to help prevent certain side effects. Your doctor will give you specific instructions about taking acetaminophen and antihistamines before each injection.

The dosing schedule typically involves step-up doses during the first few weeks. This means you'll start with smaller amounts and gradually increase to the full dose. This approach helps your body adjust to the medication and reduces the risk of serious side effects.

You don't need to take teclistamab with food since it's an injection, but staying well-hydrated before and after treatment can help you feel better overall. Your healthcare team will monitor you closely during and after each injection.

How Long Should I Take Teclistamab For?

The length of teclistamab treatment varies from person to person and depends on how well the medication works for you and how your body tolerates it. Some people may take it for several months, while others might continue for a year or longer.

Your doctor will regularly check how your multiple myeloma is responding to treatment through blood tests and other monitoring. If the cancer is responding well and you're not experiencing serious side effects, treatment may continue.

If your cancer stops responding to teclistamab or if you develop side effects that are too difficult to manage, your doctor might recommend stopping the medication and exploring other treatment options. The decision about duration is always made collaboratively between you and your healthcare team.

What Are the Side Effects of Teclistamab?

Like all cancer medications, teclistamab can cause side effects, though not everyone experiences them. Understanding what to expect can help you prepare and know when to contact your healthcare team.

The most common side effects that many people experience include fatigue, nausea, and injection site reactions where the medication was given. You might also notice changes in your blood counts, which your doctor will monitor through regular lab tests.

Common Side Effects

These side effects occur frequently but are usually manageable with proper care and monitoring:

• Fatigue and weakness
• Nausea and digestive upset
• Decreased appetite
• Injection site reactions like redness or swelling
• Low white blood cell counts
• Low red blood cell counts
• Muscle and joint pain
• Headaches
• Dizziness
• Skin rash

Most of these side effects are temporary and improve as your body adjusts to the medication. Your healthcare team can provide strategies to help manage these symptoms effectively.

Serious Side Effects

While less common, some side effects require immediate medical attention and careful monitoring:

• Cytokine release syndrome, which can cause fever, difficulty breathing, and low blood pressure
• Nervous system problems including confusion, difficulty speaking, or seizures
• Severe infections due to weakened immune system
• Tumor lysis syndrome, where cancer cells break down too quickly
• Severe allergic reactions
• Significant drops in blood cell counts

Your healthcare team will monitor you closely for these serious side effects, especially during your first few treatments. They have effective ways to manage these complications if they occur.

Rare but Important Side Effects

Some uncommon side effects may occur that require special attention:

• Severe liver problems
• Heart rhythm abnormalities
• Severe skin reactions
• Kidney problems
• Secondary cancers
• Autoimmune reactions where your immune system attacks healthy tissue

While these rare side effects are concerning, your medical team is trained to recognize and manage them promptly. Regular monitoring helps catch any problems early when they're most treatable.

Who Should Not Take Teclistamab?

Teclistamab isn't appropriate for everyone, and your doctor will carefully evaluate whether it's safe for your specific situation. Certain health conditions or circumstances may make this medication too risky.

People with active, serious infections generally shouldn't start teclistamab because the medication can weaken your immune system further. Your doctor will want to treat any infections before beginning this cancer treatment.

If you have a history of severe allergic reactions to similar medications or any components of teclistamab, this treatment likely isn't suitable for you. Your healthcare team will review your allergy history carefully before making treatment decisions.

Pregnant women should not take teclistamab because it can harm the developing baby. If you're planning to become pregnant or are currently pregnant, discuss alternative treatment options with your oncologist.

People with certain heart conditions, severe liver disease, or other serious medical problems may not be good candidates for teclistamab. Your doctor will evaluate your overall health status to determine if the benefits outweigh the risks.

Teclistamab Brand Name

Teclistamab is sold under the brand name Tecvayli. This is the commercial name you'll see on your prescription and medication labels.

When talking with your healthcare team or pharmacist, you might hear both names used interchangeably. Whether they say "teclistamab" or "Tecvayli," they're referring to the same medication.

The brand name Tecvayli is manufactured by Janssen Biotech, and it's the only version of teclistamab currently available. This helps ensure consistency in your treatment.

Teclistamab Alternatives

If teclistamab isn't suitable for you or stops working effectively, several other treatment options exist for multiple myeloma. Your oncologist can help determine which alternative might work best for your specific situation.

Other immunotherapy options include CAR-T cell therapy, where your own immune cells are modified in a laboratory to better fight cancer. This treatment requires a different process but can be very effective for some people.

Traditional chemotherapy combinations remain important alternatives, especially newer regimens that combine different types of drugs. Proteasome inhibitors, immunomodulatory drugs, and monoclonal antibodies are often used in various combinations.

Clinical trials may also offer access to experimental treatments that aren't yet widely available. Your healthcare team can help you explore whether any current trials might be appropriate for your situation.

Is Teclistamab Better Than Daratumumab?

Teclistamab and daratumumab are both effective treatments for multiple myeloma, but they work in different ways and are typically used at different stages of treatment. Neither is universally "better" than the other.

Daratumumab is often used earlier in treatment, sometimes as part of initial therapy or when multiple myeloma first returns. Teclistamab is typically reserved for cases where multiple other treatments have already been tried.

The choice between these medications depends on many factors including your previous treatments, overall health, and how your specific cancer behaves. Your oncologist will consider your complete medical picture when making treatment recommendations.

Some people might receive both medications at different times during their treatment journey. The goal is always to find the most effective treatment for your individual situation while managing side effects appropriately.